So tomorrow's "presentation" I believe is a great

So tomorrow's "presentation" I believe is a great opportunity to learn plenty... and especially with having the three of them on it.

I really hope they not only get into the efficacy/safety/medicinal aspects of Leronlimab but also the 'business' side of the equation: production/manufacturing, timing of delivery, costs/revs, the entities helping CytoDyn (there are likely many we've not even heard of yet) and of course the FDA process/status among others.

I realize some of you have been on these WSR events before and maybe expecting questions, but do they normally ask for submission of questions (during or in advance) or are they impromptu at the end of the presentation where they open the call lines? Not so sure there will be a Q/A.

I think normally a shareholder CC (Conf. Call) is one where investors can ask questions so I'm counting on that at the end of next week's session.


On a side note, these PRs, CCs and presentations are basically for the investor community... but I believe CytoDyn, especially in light of the COVID-19 tradgey... needs to up its game and get the word out to those beyond investors. The general public should be made aware but more importantly the full medical community. Not only does this help with the immediate crisis, but for patients living with cancers and HIV... as well as raising funds through investors. Many people who do not invest may very well want to put monies into a small company like CYDY and so it will grow the investor base... even before it uplifts to a more reputable exchange whereby institutional investors could come in.

Gotta go make lunch now... stay safe!